SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Wu Patty

(Last) (First) (Middle)
C/O BED BATH & BEYOND INC.
650 LIBERTY AVENUE

(Street)
UNION NJ 07083

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
08/31/2022
3. Issuer Name and Ticker or Trading Symbol
BED BATH & BEYOND INC [ BBBY ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
EVP, Brand President
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock, $.01 par value per share 4,255 D
Common Stock, $.01 par value per share 4,988(1) D
Common Stock, $.01 par value per share 2,910(2) D
Common Stock, $.01 par value per share 5,881(3) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units (RSUs)(4) (5) (5) Common Stock 14,059 0 D
Explanation of Responses:
1. Represents a grant of restricted stock units ("RSUs") awarded to the Reporting Person. RSUs are scheduled to vest equally on February 10th of each of 2023 and2024, subject to the terms, conditions and restrictions of the award agreement governing the grant.
2. Represents a grant of RSUs awarded to the Reporting Person. RSUs are scheduled to vest equally on February 10th of each of 2023 and 2024, subject to the terms, conditions and restrictions of the award agreement governing the grant.
3. Represents a grant of RSUs awarded to the Reporting Person. RSUs are scheduled to vest as follows: 2,940 RSUs on May 10, 2023 and 2,941 RSUs on May 10, 2024, subject to the terms, conditions and restrictions of the award agreement governing the grant.
4. Each RSU represents a contingent right to receive the cash value of one share of Issuer common stock upon vesting.
5. Represents a grant of RSUs awarded to the Reporting Person. RSUs are scheduled to vest as follows: 4,686 RSUs on May 10, 2023, 4,687 RSUs on May 10, 2024 and 4,686 RSUs on May 10, 2025, subject to the terms, conditions and restrictions of the award agreement governing the grant.
Remarks:
Exhibit 24 - Power of Attorney
/s/ Katherine Walden, Attorney-in-Fact 09/12/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.